30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Pete Mariani

Track

Insider profile

Performance

Overall performance
2.3
Performance over holding periods
2.3
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 27% 68% 82%
Transactions
8 38% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Financial Officer LENSAR Inc July 8, 2014 - Jan. 1, 2015
Pete Mariani's trades of Cytosorbents Corp's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-16 2026-06-15
B Purchase
40,489 -12.3%
318.32
US$2,280,635 		40,489 -12.3% 318.32 US$2,280,635
2025-08-19 2025-08-19
PrS Proposed sale
46,726
377.15
US$2,541,168 		46,726 377.15 US$2,541,168
2024-12-16 2024-12-13
B Purchase
63,471 -49.7%
285.89
US$4,838,898 		63,471 -49.7% 285.89 US$4,838,898
2024-12-13 2024-12-12
B Purchase
20,000 +5.5%
0.89
US$17,872 		20,000 +5.5% 0.89 US$17,872
2024-12-13 2024-12-11
B Purchase
11,363 +3.2%
0.89
US$10,103 		11,363 +3.2% 0.89 US$10,103
2023-12-13 2023-12-11
US AxoGen Inc (AXGN)
S Sale
7,970 -11.1%
7.50
US$59,775 		7,970 -11.1% 7.50 US$59,775
2023-12-13 2023-12-11
US AxoGen Inc (AXGN)
S Sale
3,120 -4.2%
7.51
US$23,431 		3,120 -4.2% 7.51 US$23,431
2023-12-13 2023-12-11
US AxoGen Inc (AXGN)
S Sale
1,410 -1.9%
7.52
US$10,603 		1,410 -1.9% 7.52 US$10,603
2023-12-11 2023-12-11
US AxoGen Inc (AXGN)
PrS Proposed sale
12,500
7.50
US$93,810 		12,500 7.50 US$93,810
2023-02-01 2023-02-01
US AxoGen Inc (AXGN)
PlS Planned sale
14,550 -19.0%
9.36
US$136,188 		14,550 -19.0% 9.36 US$136,188
2023-02-01 2023-01-31
US AxoGen Inc (AXGN)
PlS Planned sale
14,320 -20.5%
9.55
US$136,756 		14,320 -20.5% 9.55 US$136,756
2023-02-01 2023-01-30
US AxoGen Inc (AXGN)
PlS Planned sale
14,111 -22.4%
9.69
US$136,736 		14,111 -22.4% 9.69 US$136,736
2023-01-27 2023-01-27
US AxoGen Inc (AXGN)
PlS Planned sale
20,940 -33.2%
10.16
US$212,750 		20,940 -33.2% 10.16 US$212,750
2023-01-27 2023-01-26
US AxoGen Inc (AXGN)
PlS Planned sale
20,939 -33.2%
9.90
US$207,296 		20,939 -33.2% 9.90 US$207,296
2023-01-27 2023-01-25
US AxoGen Inc (AXGN)
PlS Planned sale
20,939 -33.2%
10.23
US$214,206 		20,939 -33.2% 10.23 US$214,206
2022-11-18 2022-11-16
US AxoGen Inc (AXGN)
PlS Planned sale
10,649 -26.4%
11.88
US$126,510 		10,649 -26.4% 11.88 US$126,510
2020-12-30 2020-12-29
US AxoGen Inc (AXGN)
S Sale
1,293 -11.1%
17.81
US$23,028 		1,293 -11.1% 17.81 US$23,028
2020-12-22 2020-12-21
US AxoGen Inc (AXGN)
S Sale
481 -7.0%
16.42
US$7,898 		481 -7.0% 16.42 US$7,898
2020-11-03 2020-10-30
US AxoGen Inc (AXGN)
PlS Planned sale
1,745 -25.9%
12.41
US$21,662 		1,745 -25.9% 12.41 US$21,662
2020-11-03 2020-10-30
US AxoGen Inc (AXGN)
PlS Planned sale
12,854 -65.6%
12.41
US$159,518 		12,854 -65.6% 12.41 US$159,518
2020-11-03 2020-10-30
US AxoGen Inc (AXGN)
PlS Planned sale
1,084 -5.2%
12.41
US$13,452 		1,084 -5.2% 12.41 US$13,452
2020-11-03 2020-10-30
US AxoGen Inc (AXGN)
PlS Planned sale
60,000 -74.4%
12.41
US$744,720 		60,000 -74.4% 12.41 US$744,720